Last updated: 2026-09-16 09:45:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Oric Pharmaceuticals, Inc. (ORIC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $12.38, with a market capitalisation of $1.31B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.23 to $14.93. This page covers its latest market performance, valuation, price trends and company information.
$1.31B | |
$12.38 | |
$40.81 | |
$2.36 | |
$12.36 | |
57.00 | |
1.53M | |
-- | |
$14.93 | |
$7.23 | |
-- | |
-- |
Oric Pharmaceuticals, Inc. (ORIC) is trading at $12.38 in pre-market trading as of 2026-09-16 08:25:00, up 0.12% ($0.02) from the previous close of $12.36
Pre-market trading shows how investors are pricing ORIC before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Oric Pharmaceuticals, Inc. (ORIC) moved from $12.86 to $12.38, representing a decline of 3.77% ($0.48).
The stock traded between $11.86 and $13.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 1.34 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 66.8%
ORIC is currently trading at $12.38, placing it 66.8% of the way from its 52-week low of $7.23 to its 52-week high of $14.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 111 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Oric Pharmaceuticals, Inc. (ORIC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.